Reckitt steps into Schiff deal


Bayer’s $1.2 billion (£740 million) bid for Schiff Nutrition, a US company specialising in vitamins and nutritional supplements, could be in trouble following a higher bid from another company. UK consumer goods giant Reckitt Benckiser has announced it is willing to pay $1.4 billion for Schiff.

‘This acquisition would provide a powerful entryway into the large and rapidly growing $30 billion global VMS [vitamin, minerals and supplements] market,’ said Reckitt Benckiser chief executive Rakesh Kapoor. ‘We are confident that the VMS market drivers, notably changing demographics and increased awareness of the health and wellness benefits of VMS products, will provide significant long term growth potential in what is currently a very fragmented market.’

Schiff was worth $259 million in sales in its 2011–12 financial year and currently employs 400 people at its headquarters and manufacturing site in Salt Lake City, Utah, and offices in Emeryville, California. Its portfolio includes big brands in the joint care (Move Free), cardiovascular health (MegaRed) and immune support (Airborne) markets.

 


Related Content

Schiff seals deal with Reckitt

23 November 2012 Business

news image

Boards approves $1.4 billion Reckitt offer as Bayer pulls out of running

BMS sells OTC drugs for $482m

14 February 2013 Business

news image

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser

Most Read

Mystery of coloured water droplets that chase and repel each other solved

19 March 2015 Research

news image

Discovery could herald sprays that hoover up dirt and keep solar panels clean

Simple cooking changes make healthier rice

23 March 2015 Research

news image

Adding oil to water, cooling and reheating rice makes fibre-like resistant starch, reducing calories

Most Commented

Worrying molecule found in bottled water

9 September 2013 Research

news image

Analysis finds a new endocrine disrupting chemical in bottled water

Impatient chemistry

28 February 2014 Last Retort

news image

Is the pressure to publish making chemists cut corners?